bpc 157/tb500 blend BPC-157 / Tb-500 10mg BPC 157 / TB500 Blend

The defining 2018 Biochemical Pharmacology study reported a methylquinolinium NNMT inhibitor reducing body weight, white-fat mass and adipocyte size in diet-induced obese mice without changing food intake, while raising intracellular NAD+ and SAM [1]

When to reduce your dose This is where many guides fail you

WHO SHOULD TAKE BPC + KPV: Liposomal BPC + KPV is ideal for patients withongoing concerns including those with compromised barrier function, gastrointestinal conditions, skin issues, and immune and inflammatory issues

Neither the information nor the products offered are meant to diagnose, treat, cure, or prevent any medical condition